—
Enter label dose
Trial reference
From your label
Enter your label dose — the gauge updates instantly.
Specific bioactive peptide preparation — generic 20 g powder is not equivalent evidence.
Educational only — not medical advice. Disclaimer.
Want the outcome before the arithmetic? The reason check opens any registry entry on this page with its trial result first, then compares your daily intake with the studied amount.
NIH DSLD market slice
Bulk CSV dump 16 January 2026 · label entries through 2025. Disclosed amounts only — proprietary blends without gram weights excluded.
Trial floors
Primary
Verisol skin trials (branded peptide) · 2.5 g over 8 weeks · Benefit shown — Specific bioactive peptide preparation — generic 20 g powder is not equivalent evidence.
Secondary
Generic hydrolyzed collagen (instrumental skin trials) · 2.5–10 g · Benefit shown — Pooled human skin trials often land in 2.5–10 g/day depending on preparation and endpoint.
Label reading notes
- Human skin trials used specific peptide preparations (often branded, e.g. Verisol) at 2.5–10 g/day. Generic "hydrolyzed collagen" or "collagen peptides" at the same gram count does not inherit those endpoints.
- Collagen marketing for Ozempic face is not evidence for surplus skin after rapid weight loss. No published RCT tests oral peptides for post–weight-loss skin laxity or facial volume.
- Branded peptide vs generic powder matters for claim matching. A beauty blend with collagen as the fourth ingredient rarely delivers a studied daily total in one serving.
- Gummies and flavored sticks often trade dose for sugar and acids; check grams of active collagen per day, not "one gummy."